Diabetes
Conditions
Keywords
telemedicine, case management, insulin, self-care
Brief summary
VA diabetes patients often have difficulty managing their self-care and accessing clinic-based services; many also lack social support to help them meet the demands of their illness. Enhanced support is especially important when undertaking and sustaining new challenging self-care tasks, such as initiating or intensifying insulin treatment regimens. Although some VAs have implemented telephone nurse care management programs supported by automated calling services, many are reluctant to adopt these models due to nursing shortages.
Detailed description
Background: VA diabetes patients often have difficulty managing their self-care and accessing clinic-based services; many also lack social support to help them meet the demands of their illness. Enhanced support is especially important when undertaking and sustaining new challenging self-care tasks, such as initiating or intensifying insulin treatment regimens. Although some VAs have implemented telephone nurse care management programs supported by automated calling services, many are reluctant to adopt these models due to nursing shortages. Objectives: This randomized trial will evaluate an intervention using a low-cost interactive voice response (IVR) exchange system to promote peer-to-peer communication among diabetes patients initiating or increasing insulin therapy under medical guidance. The intervention is based on research demonstrating the positive impact of peer support on chronic disease outcomes and self-care behaviors, our own prior studies demonstrating the effectiveness of IVR-based self-management supports for VA diabetes patients, and a successful pilot study demonstrating VA diabetes patients' willingness to participate in IVR-facilitated peer support. The Specific Aims are: (1) To evaluate the effect of IVR-facilitated peer support on diabetes patients' glycemic control (including their A1c levels, insulin doses, hypo- and hyperglycemic symptoms) and use of VA care; (2) To assess the impact of IVR-facilitated peer support on patient-centered outcomes, including patients' satisfaction with care, perceived social support, diabetes-specific quality of life, and self-care behaviors; and (3) To identify patient characteristics associated with participation and use of IVR peer support, and mediators of the intervention's impact on patient outcomes. Methods: 324 diabetes patients with inadequate glycemic control who are candidates for insulin initiation or intensification will be recruited from 2 VA facilities (Ann Arbor, and Toledo). We will pair eligible patients based on age, gender, and whether they are initiating or increasing insulin. Pairs will be randomized to either: 1) usual care; or 2) usual care in conjunction with the IVR-based peer support program. After their orientation, intervention participants will be asked to communicate weekly with their partner using the IVR exchange. The IVR service is designed to allow patients to communicate without divulging their home phone number, experiencing toll charges, or being responsible for insuring that contacts occur without the assistance of reminder prompts. Intervention patients who have achieved adequate glycemic control at their 6-month follow up will be encouraged to select a new treatment goal. Patients will continue to participate in weekly IVR calls for 6 months. Research staff will monitor the process via the Internet, and outcomes will be measured at six months. The primary endpoint will be HbA1c levels at 6 and 12-months. Secondary endpoints include other physiological measures and patient-centered outcomes. The intervention is designed to interact with standard outpatient VA staffing models. We will develop detailed training materials that facilitate implementation in other facilities and work with clinical managers to facilitate roll-out if the intervention is found to be effective. Status: Recruitment of participants is complete as well as most preliminary data analyses. 12 month data is now being analyzed.
Interventions
participants are paired with another age-matched participation. Paired peer partners were encouraged to talk weekly using a telephone platform that recorded call frequency and duration and provided automated reminders promoting peer contact.
patients are not paired in the NCM arm attended a 1.5 hour session to receive education on care manager services and diabetes educational materials and be assigned to a nurse care manager with whom they were encouraged to follow-up regularly.
Participants in the peer group were also offered three optional 1.5 hour patient-driven group sessions at month 1, 3, and 6
Sponsors
Study design
Eligibility
Inclusion criteria
* type 2 diabetes * HbA1c \> 7% * age \> 21
Exclusion criteria
* substance abuse disorder * serious psychiatric illness * serious hearing loss * life expectancy \< 12 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Glycemic Control (HbA1c) | 6 months (baseline to 6 months) | The primary outcome was change between baseline and six-month Hemoglobin A1c (HbA1c), measured with a Bayer DCA 2000+ point-of-care analyzer. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Systolic Blood Pressure Measure | change in blood pressure at 6 months | secondary outcome measure was change in blood pressure comparison of peer support group and nurse case management group from baseline to six months |
| Change in Diastolic Blood Pressure | 6 months from baseline | change in diastolic blood pressure was measured at 6 months |
| Number of Participants With Insulin Starts at 6 Months | 6 months (baseline to 6 months follow-up) | the number of insulin starts at 6 months from baseline. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Receiprocal Peer Support participants in the intervention arm are paired with a peer
Peer-support telephone calls: peers are paired during the group visit and are encouraged to speak with their partner at least once a week for the 6 month duration of the study.
group outpatient counseling visits: participants are given the option to attend 3 optional group visits with other participants and case managers. this gives them the opportunity to ask any diabetes related questions of nurses or other participants who have diabetes. | 125 |
| Nurse Case Management participants were randomized to receive usual care with an initial educational session to review lab results and discuss any questions related to educational handouts | 119 |
| Total | 244 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Death | 2 | 1 |
| Overall Study | Lost to Follow-up | 3 | 4 |
| Overall Study | Withdrawal by Subject | 3 | 0 |
Baseline characteristics
| Characteristic | Receiprocal Peer Support | Nurse Case Management | Total |
|---|---|---|---|
| Age, Continuous | 61.8 years STANDARD_DEVIATION 6.1 | 62.3 years STANDARD_DEVIATION 6.6 | 62.0 years STANDARD_DEVIATION 6.3 |
| Annual Income greater than or equal to $31,000 | 46 participants | 41 participants | 87 participants |
| Annual Income less than or equal to $30,000 | 78 participants | 71 participants | 149 participants |
| Annual Income other or unknown | 1 participants | 7 participants | 8 participants |
| Anti-hyperglycemic Medications Insulin, + or - oral medication | 70 participants | 66 participants | 136 participants |
| Anti-hyperglycemic Medications Only oral diabetes medication | 55 participants | 53 participants | 108 participants |
| Diastolic Blood Pressure | 77.1 mmHg STANDARD_DEVIATION 11.5 | 75.8 mmHg STANDARD_DEVIATION 10.7 | 76.5 mmHg STANDARD_DEVIATION 11.1 |
| Education at least some college, technical\vocational school | 91 participants | 83 participants | 174 participants |
| Education Some High School, High School | 34 participants | 35 participants | 69 participants |
| Education unknown | 0 participants | 1 participants | 1 participants |
| HbA1c | 8.02 percent HbA1c STANDARD_DEVIATION 1.32 | 7.93 percent HbA1c STANDARD_DEVIATION 1.4 | 7.98 percent HbA1c STANDARD_DEVIATION 1.4 |
| Race/Ethnicity, Customized African American | 11 participants | 11 participants | 22 participants |
| Race/Ethnicity, Customized Hispanic | 5 participants | 2 participants | 7 participants |
| Race/Ethnicity, Customized Other | 9 participants | 5 participants | 14 participants |
| Race/Ethnicity, Customized unkwown | 1 participants | 3 participants | 4 participants |
| Race/Ethnicity, Customized White, non-Hispanic | 99 participants | 98 participants | 197 participants |
| Self-Rated General Health Status - Fair or Poor Health | 59 participants | 64 participants | 123 participants |
| Sex: Female, Male Female | 0 Participants | 0 Participants | 0 Participants |
| Sex: Female, Male Male | 125 Participants | 119 Participants | 244 Participants |
| Social Support Lives alone | 29 participants | 22 participants | 51 participants |
| Social Support Lives with a spouse | 82 participants | 84 participants | 166 participants |
| Social Support Other | 14 participants | 13 participants | 27 participants |
| Systolic Blood Pressure | 140.3 mmHg STANDARD_DEVIATION 18.6 | 136.4 mmHg STANDARD_DEVIATION 16.9 | 138.4 mmHg STANDARD_DEVIATION 17.9 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 125 | 0 / 119 |
| serious Total, serious adverse events | 2 / 125 | 1 / 119 |
Outcome results
Change in Glycemic Control (HbA1c)
The primary outcome was change between baseline and six-month Hemoglobin A1c (HbA1c), measured with a Bayer DCA 2000+ point-of-care analyzer.
Time frame: 6 months (baseline to 6 months)
Population: Peer Support group: 117 of the 125 provided 6 month data and 113 provided physiologic measures. Nurse Case management participants: 114 of 119 provided 6 month data and 103 provided follow-up physiologic measures.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Reciprocal Peer Support Group | Change in Glycemic Control (HbA1c) | Baseline percent A1c | 8.02 percent HbA1c | Standard Deviation 1.32 |
| Reciprocal Peer Support Group | Change in Glycemic Control (HbA1c) | 6 month percent A1c | 7.73 percent HbA1c | Standard Deviation 1.32 |
| Nurse Case Management Group | Change in Glycemic Control (HbA1c) | Baseline percent A1c | 7.93 percent HbA1c | Standard Deviation 1.4 |
| Nurse Case Management Group | Change in Glycemic Control (HbA1c) | 6 month percent A1c | 8.22 percent HbA1c | Standard Deviation 1.74 |
Change in Diastolic Blood Pressure
change in diastolic blood pressure was measured at 6 months
Time frame: 6 months from baseline
Population: As noted earlier, for physiologic measures only 113 of the 125 peer support participants were able to provide 6 month follow-up data and 103 of 119 nurse management group provided 6 month follow-up data.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Reciprocal Peer Support Group | Change in Diastolic Blood Pressure | baseline diastolic blood pressure | 77.1 mmHg | Standard Deviation 11.5 |
| Reciprocal Peer Support Group | Change in Diastolic Blood Pressure | 6 month diastolic blood pressure | 76.8 mmHg | Standard Deviation 11.9 |
| Nurse Case Management Group | Change in Diastolic Blood Pressure | baseline diastolic blood pressure | 75.8 mmHg | Standard Deviation 10.7 |
| Nurse Case Management Group | Change in Diastolic Blood Pressure | 6 month diastolic blood pressure | 76.1 mmHg | Standard Deviation 10.6 |
Change in Systolic Blood Pressure Measure
secondary outcome measure was change in blood pressure comparison of peer support group and nurse case management group from baseline to six months
Time frame: change in blood pressure at 6 months
Population: comparison of blood pressure measure taken at baseline and then again at 6 months among the two groups. as noted, 113 peer support participants provided physiologic measures at 6 months and 103 of 119 from the nurse management group provided physiologic measures at 6 months.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Reciprocal Peer Support Group | Change in Systolic Blood Pressure Measure | baseline systolic blood pressure | 140.3 mmHg | Standard Deviation 18.6 |
| Reciprocal Peer Support Group | Change in Systolic Blood Pressure Measure | 6 month systolic blood pressure | 136.9 mmHg | Standard Deviation 16.8 |
| Nurse Case Management Group | Change in Systolic Blood Pressure Measure | baseline systolic blood pressure | 136.4 mmHg | Standard Deviation 16.9 |
| Nurse Case Management Group | Change in Systolic Blood Pressure Measure | 6 month systolic blood pressure | 135.0 mmHg | Standard Deviation 17.7 |
Number of Participants With Insulin Starts at 6 Months
the number of insulin starts at 6 months from baseline.
Time frame: 6 months (baseline to 6 months follow-up)
Population: medical charts were reviewed to obtain this information and all participant charts were reviewed
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Reciprocal Peer Support Group | Number of Participants With Insulin Starts at 6 Months | 8 participants |
| Nurse Case Management Group | Number of Participants With Insulin Starts at 6 Months | 1 participants |